Skip to main content
. 2019 Apr;5(2):a003566. doi: 10.1101/mcs.a003566

Figure 2.

Figure 2.

Stained sections of tumor sample before treatment (T1). (Upper panel) Hematoxylin and eosin (HE1: 100×, HE2: 200×); (lower panel) (100×) the epithelial marker Ber-EP4 (negative) and the mesothelioma marker calretinin (positive).